TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30829190

Group type: EXPERIMENTAL
Intervention: Befriending programme for 1 year
Number of subjects: 124

Group type: COMPARATOR
Intervention: Information about social activities only (active control)
Number of subjects: 124
Study: 29659539

Group type: EXPERIMENTAL
Intervention: Milk protein concentrate (1.15 and 0.26 g/kg on game and training days, respectively)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Energy‐matched placebo (1.37 and 0.31 g/kg of carbohydrate on game and training days, respectively)
Number of subjects: 20
Study: 27435082

Group type: COMPARATOR
Intervention: Secondary education
Number of subjects: 70506

Group type: COMPARATOR
Intervention: Tertiary education
Number of subjects: 70506
Study: 24578545

Group type: EXPERIMENTAL
Intervention: 30 mg citalopram
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy control subjects (no medication)
Number of subjects: 21
Study: 22534255

Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg orally once daily for 7 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rifampicin (600 mg orally once daily for 10 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gemigliptin monotherapy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Concurrent administration with ketoconazole
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Concurrent administration with rifampicin
Number of subjects: 24
Study: 20824184

Group type: EXPERIMENTAL
Intervention: Apoptotic tumor-autologous dendritic cell vaccine
Number of subjects: 24
Study: 18090504

Group type: EXPERIMENTAL
Intervention: Pregabalin (450 mg/day)
Number of subjects: 624

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 624
Study: 16649832

Group type: EXPERIMENTAL
Intervention: Psychoeducational groups (8 sessions over 4 to 5 months)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 236
Study: 12599083

Group type: EXPERIMENTAL
Intervention: IPT + daily iron
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: daily iron
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: IPT
Number of subjects: 546
Study: 10804679

Group type: EXPERIMENTAL
Intervention: Self-help manuals and incentives (I)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Self-help manuals, incentives, and social support groups (G)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Self-help manuals (SH)
Number of subjects: 61
Study: 8645368

Group type: EXPERIMENTAL
Intervention: picotamide
Number of subjects: 1011
Study: 1629387

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study: 3513329

Group type: EXPERIMENTAL
Intervention: Foaming antacid
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 29618012

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg methylphenidate
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg methylphenidate
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 27295475

Group type: EXPERIMENTAL
Intervention: Key feature questions during computer-based seminars
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control condition with long case narratives
Number of subjects: 87
Study: 24361242

Group type: EXPERIMENTAL
Intervention: Baseline ambulatory activity (measured in steps per day)
Number of subjects: 9306

Group type: EXPERIMENTAL
Intervention: Change in ambulatory activity (measured from baseline to 12 months)
Number of subjects: 9306
Study: 22961528

Group type: EXPERIMENTAL
Intervention: Alternative stimulation settings (pulse frequency of 31 Hz, pulse width of 210 µs)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard setting (pulse frequency of 14 Hz, pulse width of 210 µs)
Number of subjects: 15
Study: 21745792

Group type: EXPERIMENTAL
Intervention: Incentive levels of US $0, US $5, US $10, and US $20 offered for participation in the follow-up survey.
Number of subjects: 2607

Group type: EXPERIMENTAL
Intervention: Incentive offered (any level)
Number of subjects: 2607

Group type: EXPERIMENTAL
Intervention: Hispanic participants
Number of subjects: 2607

Group type: EXPERIMENTAL
Intervention: Men reporting unprotected anal intercourse
Number of subjects: 2607

Group type: EXPERIMENTAL
Intervention: Black participants
Number of subjects: 2607

Group type: EXPERIMENTAL
Intervention: Email addresses used for online financial management and daily checked email accounts
Number of subjects: 2607
Study: 19690278

Group type: EXPERIMENTAL
Intervention: Unilateral spinal anesthesia with 6-mg hyperbaric bupivacaine 0.5%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bilateral spinal anesthesia with 6-mg hyperbaric bupivacaine 0.5%
Number of subjects: 40
Study: 16488895

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 129

Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 129
Study: 12717602

Group type: EXPERIMENTAL
Intervention: Xylometazoline-Dexpanthenol
Number of subjects: 152

Group type: COMPARATOR
Intervention: Xylometazoline
Number of subjects: 152
Study: 10912880

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Voltaren) administered orally two times a day for 27 consecutive days
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Voltaren)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 9451346

Group type: EXPERIMENTAL
Intervention: 1.5% glycine irrigation solution at 70 cm height
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1.5% glycine irrigation solution at 150 cm height
Number of subjects: 40
Study: 1587749

Group type: EXPERIMENTAL
Intervention: Pathologically negative lymph nodes (Stage T-2 (B))
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Pathologically negative lymph nodes (Stage T-3,4 (C))
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Pathologic positive lymph nodes (Stage T-2 (B))
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Pathologic positive lymph nodes (Stage T-3,4 (C))
Number of subjects: 805

Group type: COMPARATOR
Intervention: Clinical positive lymph nodes
Number of subjects: 805

Group type: COMPARATOR
Intervention: Pathologic positive lymph nodes
Number of subjects: 805
Study: 3996194

Group type: EXPERIMENTAL
Intervention: Counting task with low-probability stimuli (0.17)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guessing task with varying stimulus probabilities (0.17, 0.33, 0.50)
Number of subjects: 0
Study: 31892533

Group type: EXPERIMENTAL
Intervention: NI-0101 (5 mg/kg, every 2 weeks for 12 weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: NI-0101
Number of subjects: 90
Study: 29856281

Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 32

Group type: COMPARATOR
Intervention: No enhancing intervention (Control)
Number of subjects: 32
Study: 26764069

Group type: EXPERIMENTAL
Intervention: Dalcetrapib
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 25054702

Group type: EXPERIMENTAL
Intervention: Empathic behavior by family
Number of subjects: 66

Group type: COMPARATOR
Intervention: Empathic behavior by nurses
Number of subjects: 66

Group type: COMPARATOR
Intervention: No specific empathic behavior
Number of subjects: 66
Study: 22354408

Group type: EXPERIMENTAL
Intervention: Obese premenopausal women
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Obese postmenopausal women
Number of subjects: 54

Group type: COMPARATOR
Intervention: Healthy postmenopausal controls
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Combined analysis of all postmenopausal women
Number of subjects: 54
Study: 20420907

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 mug taken twice daily for one week)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vitamin D(3) (200,000 IU weekly for 3 weeks)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (matching placebo weekly for 3 weeks)
Number of subjects: 8
Study: 17936366

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg daily for 90 days)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 89
Study: 17518377

Group type: EXPERIMENTAL
Intervention: Robotic needle driver under joystick control for spinal nerve blockade
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Robotic needle driver for lung biopsy under CT fluoroscopy
Number of subjects: 10
Study: 12401856

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (12 mg before each dialysis session for 4 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (after washout period)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Creatine monohydrate and placebo
Number of subjects: 10
Study: 10080465

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control
Number of subjects: 81
Study: 8747025

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 29
Study: 2387279

Group type: EXPERIMENTAL
Intervention: Selenite with ascorbic acid
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Selenium-rich pea flour
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Commercially available preparations (yeast Se)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 6803277

Group type: EXPERIMENTAL
Intervention: Pyridoxine plus L-tryptophan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maprotiline
Number of subjects: 20
Study: 31876668

Group type: EXPERIMENTAL
Intervention: Endurance-trained (ET)
Number of subjects: 38
Study: 30999605

Group type: EXPERIMENTAL
Intervention: Indoor areas
Number of subjects: 2573

Group type: EXPERIMENTAL
Intervention: Outdoor areas
Number of subjects: 2573

Group type: EXPERIMENTAL
Intervention: Patios
Number of subjects: 2573

Group type: EXPERIMENTAL
Intervention: Each additional smoker in patio air
Number of subjects: 2573

Group type: EXPERIMENTAL
Intervention: Each additional smoker in indoor air
Number of subjects: 2573
Study: 28522374

Group type: EXPERIMENTAL
Intervention: NNZ-2566 (doses ranged from 6.0 to 100mg/kg orally and 0.1 to 30mg/kg intravenously)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: NNZ-2566
Number of subjects: 61
Study: 25469528

Group type: EXPERIMENTAL
Intervention: Probiotics (Saccharomyces boulardii)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 23404961

Group type: EXPERIMENTAL
Intervention: 6 meals per day (6M)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 3 meals per day (3M)
Number of subjects: 15
Study: 21091547

Group type: EXPERIMENTAL
Intervention: 400 mg vitamin C/kg feed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing dietary vitamin C supplementations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 400 mg/kg or 800 mg vitamin C/kg feed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 150‐800 mg vitamin C/kg feed
Number of subjects: 0
Study: 19743983

Group type: EXPERIMENTAL
Intervention: Almond snack
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cereal bar snack
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 16514568

Group type: EXPERIMENTAL
Intervention: Wireless capsule endoscopy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (age- and sex-matched cohort undergoing capsule endoscopy for suspected small bowel disease)
Number of subjects: 14
Study: 15485574

Group type: EXPERIMENTAL
Intervention: Bicarbonate-buffered Bicavera solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lactate-containing Balance solution
Number of subjects: 60
Study: 11145322

Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg daily for 15 nights)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9033462

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 415

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 415
Study: 8509532

Group type: EXPERIMENTAL
Intervention: Coronary sinus retroperfusion support during balloon inflation
Number of subjects: 21
Study: 3663879

Group type: EXPERIMENTAL
Intervention: Theo-Dur 450 mg b.i.d.
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Theotrim 450 mg b.i.d.
Number of subjects: 5
Study: 26712355

Group type: EXPERIMENTAL
Intervention: Family violence (FV)
Number of subjects: 3175

Group type: EXPERIMENTAL
Intervention: Witnessed intimate partner violence (IPV)
Number of subjects: 3175

Group type: EXPERIMENTAL
Intervention: Child abuse
Number of subjects: 3175

Group type: EXPERIMENTAL
Intervention: Bullying (lifetime)
Number of subjects: 3175

Group type: EXPERIMENTAL
Intervention: Bullying (preceding year)
Number of subjects: 3175

Group type: EXPERIMENTAL
Intervention: Co-occurrence of FV and BV (lifetime)
Number of subjects: 3175

Group type: EXPERIMENTAL
Intervention: Co-occurrence of FV and BV (preceding year)
Number of subjects: 3175
Study: 27142632

Group type: EXPERIMENTAL
Intervention: Clinical balance measures (tandem stance, standing one leg, walking in the figure of eight, walking heel to toe on a line, walking as fast as possible for 30 m, five times sit to stand)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Five times sit to stand
Number of subjects: 82
Study: 24716835

Group type: EXPERIMENTAL
Intervention: Lubiprostone 24 mcg twice daily for 12 weeks
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 23244402

Group type: EXPERIMENTAL
Intervention: New Hope antipoverty intervention
Number of subjects: 0
Study: 20507310

Group type: EXPERIMENTAL
Intervention: PR-PASIII-PC (platelets stored in platelet additive solution with pathogen reduction)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: PASIII-PC (platelets stored in platelet additive solution without pathogen reduction)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Plasma-PC (platelets stored in plasma)
Number of subjects: 278
Study: 18247057

Group type: EXPERIMENTAL
Intervention: -1641A/-1654C haplotype carriers
Number of subjects: 240
Study: 15144762

Group type: EXPERIMENTAL
Intervention: Insecticide-treated nets (ITNs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-house residual spraying (IRS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of ITNs to IRS
Number of subjects: 0
Study: 11806592

Group type: EXPERIMENTAL
Intervention: Lavender odor oil
Number of subjects: 42

Group type: COMPARATOR
Intervention: No odor (control)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nonstressful condition (control)
Number of subjects: 42
Study: 9754845

Group type: EXPERIMENTAL
Intervention: Valproate (VPA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol (HPD) with VPA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7817331

Group type: EXPERIMENTAL
Intervention: Nadroparin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unfractionated Heparin
Number of subjects: 40
Study: 3044091

Group type: EXPERIMENTAL
Intervention: Oral acyclovir capsules, five times per day for five days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical 5 percent acyclovir in a modified aqueous cream base
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical 5 percent acyclovir in a polyethylene base
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose of oral acyclovir
Number of subjects: 0
Study: 30483832

Group type: EXPERIMENTAL
Intervention: MPFL reconstruction with lateral retinacular release (LRR)
Number of subjects: 33

Group type: COMPARATOR
Intervention: MPFL reconstruction without lateral retinacular release (no LRR)
Number of subjects: 33
Study: 28758078

Group type: EXPERIMENTAL
Intervention: Superoposterior transforaminal epidural steroid injection (SP TFESI) with 1 mL of contrast material followed by steroid injection
Number of subjects: 31
Study: 26311810

Group type: EXPERIMENTAL
Intervention: 3 g/d creatine
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: 3 g/d creatine plus 400 μg/d folic acid
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: 400 μg/d folic acid
Number of subjects: 458

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 458
Study: 24063842

Group type: EXPERIMENTAL
Intervention: Self-management counseling in patients with HFpEF
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Diuretics in patients with HFrEF
Number of subjects: 902
Study: 22011650

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 1217

Group type: COMPARATOR
Intervention: Carboplatin/paclitaxel
Number of subjects: 1217
Study: 18511215

Group type: EXPERIMENTAL
Intervention: Prenatal pelvic floor exercise (8 sessions with a physiotherapist between 6 and 8 months of pregnancy)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Sole written instructions
Number of subjects: 280
Study: 17149461

Group type: EXPERIMENTAL
Intervention: Increased access to spirometry in asthma education centres (AECs) during the second six-month period.
Number of subjects: 303

Group type: COMPARATOR
Intervention: No spirometry offered in AECs during the study.
Number of subjects: 303
Study: 12492792

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine 0.2% plus sufentanil 0.2 micro g ml‐1, at 5 ml h‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous femoral block with the same analgesic mixture
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous intraarticular infusion of ropivacaine 0.2% plus sufentanil 0.2 micro g ml‐1, at 5 ml h‐1
Number of subjects: 60
Study: 10692189

Group type: EXPERIMENTAL
Intervention: Midazolam (0.05 mg/kg up to 2 mg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 104
Study: 9348574

Group type: EXPERIMENTAL
Intervention: UFT 400 mg/day for 6 months plus prednimustine 60 mg/m2 for 7 consecutive days, every 28 days in 6 cycles (arm B)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/day for 1 year plus UFT 400 mg/day for 6 months (arm B)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg/day for 1 year (arm A)
Number of subjects: 409
Study: 8122356

Group type: EXPERIMENTAL
Intervention: Cisapride (0.1 mg/kg bw intramuscularly at 8‐h intervals)
Number of subjects: 70
Study: 3537899

Group type: EXPERIMENTAL
Intervention: Dyazide (50 mg triamterene and 25 mg hydrochlorothiazide)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 30058731

Group type: EXPERIMENTAL
Intervention: Subthreshold diode micropulse (SDM) laser
Number of subjects: 68

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 68
Study: 30383531

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) application during ACL reconstruction (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group without PRF application (Group 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) application (Group 1)
Number of subjects: 40
Study: 27364321

Group type: EXPERIMENTAL
Intervention: High-intensity running trials (500m, 1000m, 1500m) at 90% of maximal speed
Number of subjects: 6
Study: 24099704

Group type: EXPERIMENTAL
Intervention: Active Online Learning (AOL)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Passive Online Learning (POL)
Number of subjects: 216
Study: 22019482

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 4656

Group type: COMPARATOR
Intervention: Systemic chemotherapy
Number of subjects: 4656
Study: 20164315

Group type: EXPERIMENTAL
Intervention: Soy milk (16.98 mg genistein and 5.40 mg daidzein aglycone equivalents per dose)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Soy supplement (5.27 mg genistein and 17.56 mg daidzein aglycone equivalents per dose)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (no soy isoflavones)
Number of subjects: 31
Study: 18788506

Group type: EXPERIMENTAL
Intervention: Cefepime 1 g q12 h and clindamycin 900 mg q8 h (group 2)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Ceftriaxone 1 g q12 h and clindamycin 900 mg q8 h (group 1)
Number of subjects: 140
Study: 16128647

Group type: EXPERIMENTAL
Intervention: Implantable drug delivery system (IDDS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comprehensive medical management (CMM)
Number of subjects: 30
Study: 11892681

Group type: EXPERIMENTAL
Intervention: Active treatment using TherMatrx TMx-2000
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 200
Study: 9578059

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with autologous stem cell support
Number of subjects: 218

Group type: COMPARATOR
Intervention: Standard-dose salvage chemotherapy
Number of subjects: 218
Study: 7510351

Group type: EXPERIMENTAL
Intervention: 6 million kallikrein inactivator units of aprotinin (high-dose group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2 million kallikrein inactivator units of aprotinin (low-dose group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: All groups (high-dose, low-dose, control)
Number of subjects: 45
Study: 2573113

Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Clemastine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 4395906

Group type: EXPERIMENTAL
Intervention: Isoprenaline 400 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orciprenaline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other bronchodilator aerosols (doses adjusted to match peak response of isoprenaline)
Number of subjects: 0
Study: 30312378

Group type: EXPERIMENTAL
Intervention: Methods 1 (weighting methods based on simulated individual data)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methods 2 (method of moments)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Method 3 (weighted trial's subgroup-specific treatment effects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Method 4 (calculated expected absolute benefits)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aggregate data methods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gold-standard method (individual data from both the trial and CPRD)
Number of subjects: 0